Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TEVA - Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript


TEVA - Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript

2024-05-08 11:32:14 ET

Teva Pharmaceutical Industries Limited (TEVA)

Q1 2024 Earnings Conference Call

May 08, 2024, 08:00 AM ET

Company Participants

Ran Meir - Head, Investor Relations

Richard Francis - Chief Executive Officer

Eric Hughes - Head, R&D & Chief Medical Officer

Eli Kalif - Chief Financial Officer

Conference Call Participants

Umer Raffat - Evercore ISI

David Amsellem - Piper Sandler

Ash Verma - UBS

Balaji Prasad - Barclays

Jason Gerberry - Bank of America

Yifeng Liu - HSBC

Thibault Boutherin - Morgan Stanley

Chris Schott - JPMorgan

Glen Santangelo - Jefferies

Presentation

Operator

Hello, and welcome to the First Quarter 2024 Teva Pharmaceuticals Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today. [Operator Instructions]

I'll now hand it over to your host, Ran Meir, Head of Investor Relations. Please go ahead.

Ran Meir

Thank you Alex, and thank you everyone for joining us today.

We hope you have had a chance to review our Q1 results press release along with the press release announcing positive Phase 3 results from olanzapine LAI trial, both issued earlier this morning. Copies of these press releases, along with the slides presented during this call, are available on our website at ir.tevapharm.com.

Please review our forward-looking statements on Slide #2. Additional information on these statements and our non-GAAP financial measures can be found on our earnings release and in our SEC forms 10-K and 10-Q.

To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva's first quarter results and business performance, recent events, and our focus and priorities going forward; then, Dr. Eric Hughes, our Head of R&D and Chief Medical Officer, will discuss progress on our innovative pipeline; our CFO, Eli Kalif, will follow up by reviewing the first quarter financial results in more detail.

Please note that today's call will run approximately one hour.

And with that, I will turn the call over to Richard. Richard, if you would, please....

For further details see:

Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript
Stock Information

Company Name: Teva Pharmaceutical Industries Limited American Depositary Shares
Stock Symbol: TEVA
Market: NYSE
Website: tevapharm.com

Menu

TEVA TEVA Quote TEVA Short TEVA News TEVA Articles TEVA Message Board
Get TEVA Alerts

News, Short Squeeze, Breakout and More Instantly...